03.81.2018 - Kyoto University Chooses Intel Machine and Deep Learning Tech to Tackle Drug Discovery, Medicine and Healthcare Challenges

p>Kyoto University Graduate School of Medicine*, one of Asia’s leading research-oriented institutions, has recently chosen Intel® Xeon® Scalable processors to power its clinical genome analysis cluster and its molecular simulation cluster. These clusters will aid in Kyoto’s search for new drug discoveries and help reduce research and development costs. The Intel Xeon Scalable platform offers …... - View Press Release - Visit Intel Corporation